Biotricity, Inc. (BTCY)

Market Cap	3.80M -71.2%
Revenue (ttm)	15.45M +16.5%
Net Income	-4.70M
EPS	-0.18
Shares Out	29.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49
Open	0.1440
Previous Close	0.1300
Day's Range	0.1310 - 0.1440
52-Week Range	0.1000 - 0.7536
Beta	1.31
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which su...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Waqaas Al-Siddiq
• Employees: 46
• Stock Exchange: OTCMKTS
• Ticker Symbol: BTCY

Financial Performance

In fiscal year 2025, Biotricity's revenue was $13.79 million, an increase of 14.32% compared to the previous year's $12.06 million. Losses were -$11.94 million, -20.01% less than in 2024.